• Company
• Combo drugs strong in the COPD treatment market
• by Son, Hyung-Min Oct 25, 2023 05:24am

• Opinion
• [Reporter’s View] Asthma drugs reimb through diff tracks
• by Eo, Yun-Ho Oct 25, 2023 05:24am

• Company
• Hanmi’s P3T for ’Korean GLP-1 obesity drug’ is approved
• by Lee, Seok-Jun Oct 25, 2023 05:24am

• Company
• Celltrion’s Remsima SC was approved in the US
• by Chon, Seung-Hyun Oct 24, 2023 05:22am

• Policy
• Severe asthma txs Nucala and Cinqair are to be reimbursed
• by Lee, Jeong-Hwan Oct 24, 2023 05:22am

• Company
• CMV treatment Livtencity can be prescribed at general hosp
• by Eo, Yun-Ho Oct 24, 2023 05:21am

• Policy
• TZD combined DPP4i-SGLT2i complex
• by Lee, Tak-Sun Oct 24, 2023 05:21am

• Company
• Next-generation antibiotic Zavicefta can be prescribed
• by Eo, Yun-Ho Oct 23, 2023 05:14am

• Company
• New anemia tablets offer increased options
• by Nho, Byung Chul Oct 23, 2023 05:14am

• Company
• Forxiga generics take over 30% of market in 6 mths
• by Kim, Jin-Gu Oct 23, 2023 05:14am